{"DataElement":{"publicId":"14745989","version":"1","preferredName":"FLT3 Gene Mutation Abnormality Type","preferredDefinition":"A response that answers questions related to the type of genetic abnormality at the chromosomal level of the FLT3 Gene.","longName":"14745983v1.00:14745985v1.00","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"14745983","version":"1","preferredName":"FLT3 Gene Mutation Abnormality","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","longName":"14745982v1.00:3193868v1.00","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"14745982","version":"1","preferredName":"FLT3 Gene","preferredDefinition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","longName":"C24399","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Gene","conceptCode":"C24399","definition":"This gene plays a role in hematopoiesis and may function as a growth factor receptor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E19B79-29B2-6E05-E063-731AD00AA0C0","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3193868","version":"1","preferredName":"Mutation Abnormality","preferredDefinition":"A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.","longName":"C45576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D5F2496-5D1D-3EDC-E040-BB89AD43173D","latestVersionIndicator":"Yes","beginDate":"2011-02-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10E19B79-29B3-6E05-E063-731AD00AA0C0","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":"2/8/24 Created for ECOG-ACRIN OPEN eligibility questions.  No Alts must be exact.  BF","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14745985","version":"1","preferredName":"Mutation Abnormality Type","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Something distinguishable as an identifiable class based on common qualities.","longName":"14745985v1.00","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ITD VAF greater than or equal to 0.33","valueDescription":null,"ValueMeaning":{"publicId":"14745986","version":"1","preferredName":"ITD VAF greater than or equal to 0.33","longName":"14745986v1.00","preferredDefinition":"ITD VAF greater than or equal to 0.33","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E22A55-D1AB-1490-E063-731AD00A7842","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E22A55-D1AE-1490-E063-731AD00A7842","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"ITD VAF less than 0.33","valueDescription":null,"ValueMeaning":{"publicId":"14745987","version":"1","preferredName":"ITD VAF less than 0.33","longName":"14745987v1.00","preferredDefinition":"ITD VAF less than 0.33","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E22A55-D1AC-1490-E063-731AD00A7842","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E22A55-D1AF-1490-E063-731AD00A7842","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"TKD","valueDescription":null,"ValueMeaning":{"publicId":"14745988","version":"1","preferredName":"TKD","longName":"14745988v1.00","preferredDefinition":"TKD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10E22A55-D1AD-1490-E063-731AD00A7842","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10E22A55-D1B0-1490-E063-731AD00A7842","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","deletedIndicator":"No"},{"value":"ITD VAF less than 0.33 or TKD","valueDescription":null,"ValueMeaning":{"publicId":"14767186","version":"1","preferredName":"ITD VAF less than 0.33 or TKD","longName":"14767186v1.00","preferredDefinition":"ITD VAF less than 0.33 or TKD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11E7EF3F-C58F-6EB8-E063-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2024-02-21","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-21","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11E7EF3F-C590-6EB8-E063-731AD00ADA9F","beginDate":"2024-02-21","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-21","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6703551","version":"1","preferredName":"Mutation Abnormality Type","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:Something distinguishable as an identifiable class based on common qualities.","longName":"C45576:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4F09E-2F68-62BE-E053-F662850ADAAC","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10E22067-AFB0-1312-E063-731AD00A41A9","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":"2/8/24 Created for ECOG-ACRIN OPEN Eligibility questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"FLT3 mutation","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10E28DC3-0560-28C7-E063-731AD00A3474","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeDescription":null,"administrativeNotes":"2/8/24 Created for ECOG-ACRIN Open Eligibility questions. BF","unresolvedIssues":null,"deletedIndicator":"No"}}